254 related articles for article (PubMed ID: 756130)
1. [Steroid receptors--their meaning in the treatment of breast neoplasms].
Aiginger P
Acta Med Austriaca; 1978; 5(4-5):156-8. PubMed ID: 756130
[TBL] [Abstract][Full Text] [Related]
2. [The importance of steroid receptors for the prognosis and hormone treatment of breast cancer patients: a retrospective study in Southeastern Netherlands].
Voogd AC; Crommelin MA; Repelaer van Driel OJ; Tutein Nolthenius-Puylaert MC; Vreugdenhil G; Coebergh JW
Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1772-8. PubMed ID: 9856143
[TBL] [Abstract][Full Text] [Related]
3. [Steroid hormone receptors and survival in breast cancer patients].
Ivanova OA; Tsyrlina EV; Moiseenko VM; Semiglazov VF
Vopr Onkol; 1986; 32(6):71-6. PubMed ID: 3727485
[TBL] [Abstract][Full Text] [Related]
4. [Steroid hormone receptors in breast cancer].
Nomura Y
Rinsho Byori; 1990 Jan; 38(1):26-30. PubMed ID: 2308219
[TBL] [Abstract][Full Text] [Related]
5. [Hormone receptors and breast cancer prognosis].
Saez S; Pichon MF
Pathol Biol (Paris); 1983 Dec; 31(10):801-8. PubMed ID: 6366701
[TBL] [Abstract][Full Text] [Related]
6. [Significance of hormone receptors of breast cancer cells for the duration of a disease-free interval].
Zielinski CC; Kuzmits R; Kubista E; Salzer H; Staffen A; Aiginger P; Spona J
Wien Klin Wochenschr; 1985 May; 97(11):493-7. PubMed ID: 4013343
[TBL] [Abstract][Full Text] [Related]
7. [Degree of manifestation of therapeutic pathomorphosis and the nature of the change in the estrogen and progesterone receptors after the radiation and chemotherapy of breast cancer].
Ermilova VD; Koposova TL; Murav'ëva NI; Kuz'mina ZV
Vopr Onkol; 1985; 31(12):69-73. PubMed ID: 4082510
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic value of estrogen and progesterone receptors in the operable breast cancer: results of a uni- and multifactorial analysis].
Chevallier B; Heintzman F; Asselain B; Dauce JP; Bastit P; Graic Y; Brunelle P; Basuyau JP; Comoz M
Bull Cancer; 1988; 75(1):23-36. PubMed ID: 3359056
[TBL] [Abstract][Full Text] [Related]
9. Steroid hormone receptors in the management of human breast cancer.
Knight WA; Osborne CK; Yochmowitz MG; McGuire WL
Ann Clin Res; 1980 Oct; 12(5):202-7. PubMed ID: 7015982
[TBL] [Abstract][Full Text] [Related]
10. Steroid receptors in breast cancer.
Desombre ER
Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
[TBL] [Abstract][Full Text] [Related]
11. Estrogen and progesterone receptors in human breast cancer with concomitant assay of plasma 17beta-estradiol, progesterone, and prolactin levels.
Nagai R; Kataoka M; Kobayashi S; Ishihara K; Tobioka N; Nakashima K; Naruse M; Saito K; Sakuma S
Cancer Res; 1979 May; 39(5):1834-40. PubMed ID: 427816
[TBL] [Abstract][Full Text] [Related]
12. [Steroid hormone receptors and their relevance for the therapy of mammary cancers (author's transl)].
Heise E
Arch Geschwulstforsch; 1981; 51(8):727-36. PubMed ID: 7041847
[TBL] [Abstract][Full Text] [Related]
13. Relationship of presence of progesterone receptors to prognosis in early breast cancer.
Pichon MF; Pallud C; Brunet M; Milgrom E
Cancer Res; 1980 Sep; 40(9):3357-60. PubMed ID: 7427948
[TBL] [Abstract][Full Text] [Related]
14. [Correlations between hormone receptors, tumor size and axillary lymph node involvement in breast carcinoma. Initial results].
Baldi F; Gallo A; Giannantoni C; Dell'Agli P; Caselli G
Minerva Chir; 1988 Mar; 43(6):507-9. PubMed ID: 3399106
[No Abstract] [Full Text] [Related]
15. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast.
Friedman NS; Freedman MD
Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198
[TBL] [Abstract][Full Text] [Related]
16. Progesterone and estrogen receptors as prognostic variables in breast cancer.
Mason BH; Holdaway IM; Mullins PR; Yee LH; Kay RG
Cancer Res; 1983 Jun; 43(6):2985-90. PubMed ID: 6850609
[TBL] [Abstract][Full Text] [Related]
17. [Factors affecting estrogen and progesterone receptors in primary breast cancer].
Kuno K; Fukami A; Hori M; Kasumi F; Yoshimoto K
Gan No Rinsho; 1983 May; 29(6):621-7. PubMed ID: 6876431
[TBL] [Abstract][Full Text] [Related]
18. Biologic tumor markers, lymph node status, and decision about adjuvant chemotherapy for breast cancer.
Velanovich V
Am Surg; 1997 Apr; 63(4):330-3. PubMed ID: 9124752
[TBL] [Abstract][Full Text] [Related]
19. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options.
Gentilini O; Masullo M; Rotmensz N; Peccatori F; Mazzarol G; Smeets A; Simsek S; De Dosso S; Veronesi P; Intra M; Zurrida S; Viale G; Goldhirsch A; Veronesi U
Eur J Surg Oncol; 2005 Apr; 31(3):232-6. PubMed ID: 15780556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]